KEPETAM 500 mg/5 ml (100 mg/ml) Price

Overview

Welcome to Dwaey, specifically on KEPETAM 500 mg/5 ml (100 mg/ml) Concentrate for Solution for Infusion page.
This medicine contains an important and useful components, as it consists of Levetiracetam .
KEPETAM 500 mg/5 ml (100 mg/ml) is available in the market in concentration 500 mg/5 ml (100 mg/ml) and in the form of Concentrate for Solution for Infusion.

HIKMA PHARMACEUTICALS is the producer of KEPETAM 500 mg/5 ml (100 mg/ml) and it is imported from JORDAN, The most popular alternatives of KEPETAM 500 mg/5 ml (100 mg/ml) are listed downward .

Mode Of Action

Anticonvulsant used in the treatment of partial seizures. The precise mechanism of anticonvulsant effect is unknown.

Indication

• Partial seizures

Precaution

Renal and hepatic impairment; pregnancy, lactation; patients undergoing haemodialysis. If psychotic symptoms (eg hallucination) and behavioural symptoms (eg agitation, anxiety) occur, reduce dosage. Abrupt withdrawal may result in increased seizure frequency. May impair ability to drive or operate machinery during initial therapy. Lactation: Excreted in breast milk; not recommended

Side Effects

• >10% Asthenia (11-15%)
• Headache (14-19%)
• Infection (11-15%)
• Increased blood pressure (17% in children < 4 years)
• Somnolence (11-15%)
• Drowsiness (2-23%)
• Fatigue (10-11%)
• Anorexia (3-13%)
• Weakness (9-15%)
• Nasopharyngitis (7-15%)
• Cough (2-11%) 1-10% Viral infection (2%)
• Asthma (2%)
• Dizziness (5-9%)
• Nervousness (2-10%)
• Amnesia (2%)
• Anxiety (2-3%)
• Ataxia (3%)
• Depression (2-5%)
• Hostility (10%)
• Paresthesia (2%)
• Sinusitis (2%)
• Diplopia (2%)
• Amblyopia (2%)
• Conjunctivitis (2-3%)
• Albuminuria (4%) <1% Abnormal hepatic function tests
• Dyskinesia
• Eczema
• Neutropenia
• Decreased hematocrit
• Leukopenia
• Suicidal tendencies
• Hepatitis
• Pancreatitis
• Bone marrow suppression
• Epidermal necrolysis

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks